Evidence map›Paper›PMID 31257941›Full record

ArticleDrug delivery2019

Synergistic photothermal/photodynamic suppression of prostatic carcinoma by targeted biodegradable MnO

Dewang Zeng, Lei Wang, Lu Tian, Shili Zhao, Xianfeng Zhang, Hongyan Li

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. DFT study of TiRSC advances · 2024
    Article
  7. Article
  8. TME-Activated MnOInternational journal of nanomedicine · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Role of main RNA modifications in cancer: NSignal transduction and targeted therapy · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. 2D layered nanomaterials for therapeutics delivery.Current opinion in biomedical engineering · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dewang Zenga Department of Nephrology , Huadu District People's Hospital of Guangzhou, Southern Medical University , Guangzhou , China.
Lei Wangb Guizhou Population and Family Planning Science Research and Technology Guidance Institute , Guiyang , China.
Lu Tiana Department of Nephrology , Huadu District People's Hospital of Guangzhou, Southern Medical University , Guangzhou , China.
Shili Zhaoa Department of Nephrology , Huadu District People's Hospital of Guangzhou, Southern Medical University , Guangzhou , China.
Xianfeng Zhangc Department of Gastroenterology , Huadu District People's Hospital of Guangzhou, Southern Medical University , Guangzhou , China.
Hongyan Lia Department of Nephrology , Huadu District People's Hospital of Guangzhou, Southern Medical University , Guangzhou , China.
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biodegradability and clearance of metal-based nanomaterials have been questioned worldwide, which have greatly limited their clinical translation. Herein, ultrathin manganese dioxide (MnO

Indexed as

Biodegradable PlasticsCarcinomaCell Line, TumorChlorophyllidesHeLa CellsHumansMaleManganese CompoundsNanostructuresOxidesPC-3 CellsPeptides, CyclicPhotochemotherapyPolyethylene GlycolsPorphyrinsProstatic NeoplasmsBiodegradable PlasticsChlorophyllidescyclic arginine-glycine-aspartic acid peptideManganese Compoundsmanganese dioxideOxidesPeptides, CyclicphytochlorinPolyethylene GlycolsPorphyrinsCe6MnO nanosheetphotodynamic therapyphotothermal therapytargeted delivery

Identifiers

PMID31257941
PMCPMC6610525
OpenAlexW2954443492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.